Search results
Diplopia (Double Vision) and Treatment Effectiveness
Verywell Health· 3 days agoThey will also determine if your eyes are misaligned by shining a light...also order a blood test to see if an underlying condition (such as Graves' ...
World Malaria Day 2024: Health tips for quick recovery | - Times of India
The Times of India· 6 days agoMalaria, a life-threatening disease transmitted through the bite of infected mosquitoes, poses a...
6 lifestyle changes to reverse fatty liver disease | The Times of India
The Times of India· 7 days agoFatty liver disease is one of those diseases that attack your health silently. What makes it even...
Prime Medicine gets green light for trials of first-ever prime editing drug
Clinical Trials Arena· 8 hours agoPrime Medicine has been granted approval by the US Food and Drug Association (FDA) to initiate...
WHO calls for equitable health access to prevention, diagnosis, treatment for malaria - ET...
The Economic Times· 6 days ago"Moreover, by leveraging digital technology, we can better understand the diverse health needs of...
World Malaria Day: 8 Essential Steps For A Speedy Recovery From Malaria
Indiatimes· 5 days agoWorld Malaria Day is observed annually on April 25th. It's a day dedicated to raising awareness...
King Charles to return to public duties after 'positive' cancer treatment
Aberdeen Live· 11 hours agoKing Charles has been receiving care as an outpatient since early February, and sources have said...
Anosognosia: Everything You Need to Know
Verywell Health· 7 days agoSomeone living with anosognosia may not be aware they have an illness and need treatment. They might doubt their diagnosis, attribute signsand ...
World Malaria Day: How climate change is worsening the spread of the disease
Firstpost· 5 days agoDo not take malaria lightly. There were an estimated 249 million cases of malaria around the world...
Bitterroot Bio kickstarts Phase I trial for cardiovascular disease candidate
Clinical Trials Arena· 1 day agoThe study involves healthy participants, who will receive subcutaneous administrations of BRB-002 –...